Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — Galera Therapeutics, Inc. (NASDAQ: GRTX) this week unveiled its financial results for the third quarter of 2023, alongside a series of significant corporate updates that signal a …
Galera Therapeutics Reports Q3 2023 Financial Results Amid Strategic Shift Read More
CHESTERBROOK, PA — Biopharmaceutical company Trevena, Inc. (NASDAQ: TRVN) has reported its Q3 2023 financial results, shedding light on a net loss attributable to common stockholders of $7.9 million, or …
Trevena Reports Promising Q3 2023 Results, Reveals Progress in TRV045 Studies and OLINVYK Sales Read More
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …
Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced disappointing top-line results from a Phase 2b study of zunsemetinib (ATI-450) in patients with moderate to severe rheumatoid arthritis …
Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint Read More
MALVERN, PA — Cantaloupe, Inc. (NASDAQ: CTLP), a leading provider of technology solutions for self-service commerce, recently reported its financial results for the first quarter of fiscal year 2024, ending …
Cantaloupe, Inc. Reports Strong First Quarter Fiscal Year 2024 Results Amid Global Expansion Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced its third-quarter financial results ending September 30, 2023, and provided a corporate update that includes the completion of a significant merger …
Immunome Merges with Morphimmune, Secures $125M in Funding for Accelerated Cancer Therapy Development Read More
EXTON, PA — Bentley Systems, Incorporated (NASDAQ: BSY), a leading global provider of comprehensive software solutions for advancing infrastructure, has recently announced its operating results for the third quarter and …
Bentley Systems Reports Strong Third Quarter 2023 Operating Results with 14.3% Revenue Growth Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, has recently announced the approval of inducement grants by its Compensation Committee. The grants, which cover 40,700 …
TELA Bio Announces Inducement Grants for Newly-Hired Employees Under Nasdaq Rule Read More
MALVERN, PA — Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced the commencement of its Phase 1/2 GARDian clinical trial for OCU410ST (AAV5-hRORA), a gene therapy candidate being developed to …
Ocugen Initiates Phase 1/2 GARDian Clinical Trial for Stargardt Disease Therapy Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading player in the biotechnology industry, recently reported its financial results for the third quarter of 2023, marking an impressive 11th …
TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth Read More